ArticleMolecules (Basel, Switzerland)2026
Derivatization-Assisted Lipase-Mediated Separation of Optically Pure α-Cyclopentylmandelic Acid Through Enhanced Substrate Recognition.
Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
α-Cyclopentylmandelic acid (CPMA) is a chiral α-hydroxycarboxylic acid valuable in pharmaceutical synthesis and asymmetric catalysis. However, it remains challenging to prepare with high optical purity due to its unique steric structure. This study established a chiral resolution strategy using derivatization-assisted lipase-catalyzed kinetic resolution to efficiently prepare optically pure CPMA. We employed acetoxyacetyl chloride derivatization to introduce a diester structure into CPMA that lipase recognizes efficiently and identified recombinant Cal B as the optimal catalyst through enzyme screening. Theoretical calculations suggested that the activity difference resulting from the derivatization strategy stems from spatial recognition rather than electronic effects; the significant difference in binding affinity between the R- and S-substrates provides the driving force for subsequent time-dependent separation. By controlling the reaction time, the (R)- and (S)-CPMA enantiomers could be selectively prepared. This achieved ee values exceeding 99.5% for both enantiomers, with isolated yields over 38% for each. Cal B was immobilized on an ESR carrier and retained good catalytic activity after 12 reuse cycles. The resulting (R)-CPMA was successfully used to synthesize sofpironium bromide, thereby validating the practical feasibility of this process. This strategy provides an effective, environmentally friendly enzymatic route to highly sterically hindered chiral α-hydroxycarboxylic acids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.